Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Challenges and importance of long-term treatment for newly diagnosed multiple myeloma patients; community-based trial data

Novel multi-antigen targeted CAR-NK cell for the treatment of B cell malignancies

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise

Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients

Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma

Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients

CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions

Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients

Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have high response rate

Cellular immunotherapy for B cell cancers shows promise